These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 12717054)

  • 1. Depression and Adjustment Disorder in Patients With HIV Disease.
    Angelino AF
    Top HIV Med; 2002; 10(5):31-35. PubMed ID: 12717054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance abuse and HIV infection.
    Francis H
    Top HIV Med; 2003; 11(1):20-4. PubMed ID: 12717047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone disorders, hypertension, and mitochondrial toxicity in HIV disease.
    Newman MD
    Top HIV Med; 2003; 11(1):10-5. PubMed ID: 12717045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prioritizing primary care in HIV: comorbidity, toxicity, and demography.
    Justice AC
    Top HIV Med; 2006 Dec-2007 Jan; 14(5):159-63. PubMed ID: 17237557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of depressive symptoms at ART initiation on HIV clinical progression and mortality: implications in clinical practice.
    Villes V; Spire B; Lewden C; Perronne C; Besnier JM; Garré M; Chêne G; Leport C; Carrieri MP; Le Moings V;
    Antivir Ther; 2007; 12(7):1067-74. PubMed ID: 18018765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of psychiatric disorders on the HIV epidemic.
    Angelino AF
    Top HIV Med; 2008; 16(2):99-103. PubMed ID: 18591718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV testing: rationale for changing recommendations.
    Janssen RS
    Top HIV Med; 2007; 15(1):6-10. PubMed ID: 17406078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Making sense of the HIV immune response.
    Goepfert PA
    Top HIV Med; 2003; 11(1):4-8. PubMed ID: 12717044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
    Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B;
    Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV in adolescents and young adults: half of all new infections in the United States.
    Futterman DC
    Top HIV Med; 2005; 13(3):101-5. PubMed ID: 16170227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major Depressive Disorder and HIV-1 Infection: A Review of Treatment Trials.
    Elliott AJ; Roy-Byrne PP
    Semin Clin Neuropsychiatry; 1998 Apr; 3(2):137-150. PubMed ID: 10085200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depressive symptoms in HIV disease.
    Eller LS
    Nurs Clin North Am; 2006 Sep; 41(3):437-53, vii. PubMed ID: 16908235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of treatment studies of depression in HIV.
    Olatunji BO; Mimiaga MJ; O'Cleirigh C; Safren SA
    Top HIV Med; 2006; 14(3):112-24. PubMed ID: 16946456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression and CD4 cell count among persons with HIV infection in Uganda.
    Kaharuza FM; Bunnell R; Moss S; Purcell DW; Bikaako-Kajura W; Wamai N; Downing R; Solberg P; Coutinho A; Mermin J
    AIDS Behav; 2006 Jul; 10(4 Suppl):S105-11. PubMed ID: 16802195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens.
    Hogg RS; Yip B; Kully C; Craib KJ; O'Shaughnessy MV; Schechter MT; Montaner JS
    CMAJ; 1999 Mar; 160(5):659-65. PubMed ID: 10102000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Depression in HIV infection: prevalence, risk factors and management].
    Wolff L C; Alvarado M R; Wolff R M
    Rev Chilena Infectol; 2010 Feb; 27(1):65-74. PubMed ID: 20140318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: outcomes from a population-based cohort.
    Braitstein P; Montessori V; Chan K; Montaner JS; Schechter MT; O'Shaughnessy MV; Hogg RS
    AIDS Care; 2005 May; 17(4):505-15. PubMed ID: 16036236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons.
    Ammassari A; Antinori A; Aloisi MS; Trotta MP; Murri R; Bartoli L; Monforte AD; Wu AW; Starace F
    Psychosomatics; 2004; 45(5):394-402. PubMed ID: 15345784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment perceptions and attitudes of older human immunodeficiency virus-infected adults.
    Wutoh AK; Brown CM; Dutta AP; Kumoji EK; Clarke-Tasker V; Xue Z
    Res Social Adm Pharm; 2005 Mar; 1(1):60-76. PubMed ID: 17138466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.